News Release
Dec. 15, 2020
Surgical and injectable drug approaches are equally effective for treatment of bleeding inside the eye from proliferative diabetic retinopathy, according to a National Institutes of Health-supported clinical study from the DRCR Retina Network.
News Release
Sept. 30, 2020
A nationwide study funded by the National Institutes of Health will seek to discover the cause of several unusual forms of diabetes. Through research efforts at 20 U.S. research institutions, the study aims to discover new forms of diabetes, understand what makes them different, and identify their causes.
News Release
Aug. 26, 2020
A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — is safe and effective at managing blood glucose levels in children as young as age six with type 1 diabetes. The trial was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health.
News Release
July 24, 2020
Funded by the National Institutes of Health, six U.S. research institutions are launching the first-ever multicenter network to study diabetic foot ulcers, a common and burdensome complication of diabetes and the leading cause of lower limb amputations in the United States. The Diabetic Foot Consortium (DFC) aims to lay the foundation for a clinical trial network to test how to improve diabetic wound healing and prevent amputations among the 27 million American adults with diabetes.
News Release
June 25, 2020
In the largest exercise research program of its kind, researchers are poised to collect and turn data from nearly 2,600 volunteers into comprehensive maps of the molecular changes in the body due to exercise.
News Release
June 15, 2020
The National Institutes of Health has launched a centralized, secure enclave to store and study vast amounts of medical record data from people diagnosed with coronavirus disease across the country.
News Release
June 11, 2020
Scientists have developed a new test that can help identify people who are likely to develop hepatocellular carcinoma (HCC), the most common form of liver cancer. The approach uses a simple blood test to check for the patient’s previous exposure to certain viruses.
News Release
May 27, 2020
With a focus on precision nutrition, the 2020-2030 Strategic Plan for National Institutes of Health Nutrition Research reflects input from the nutrition research community and the wide range of nutrition research supported across NIH.
Research Update
May 1, 2020
Researchers have shown that treatment with the drug mirabegron stimulates the formation of beige fat tissue in people with insulin resistance and overweight/obesity, resulting in several metabolic health benefits
News Release
Feb. 26, 2020
NIH has launched a $1 million Technology Accelerator Challenge to spur the design and development of non-invasive, handheld, digital technologies to detect, diagnose and guide therapies for diseases with high global and public health impact. The challenge is focused on sickle cell disease, malaria and anemia.
Research Update
Feb. 14, 2020
Scientists demonstrated that rates of both type 1 and type 2 diabetes continue to increase in people under the age of 20 in the United States, with higher rates of increase among racial/ethnic minority youth.
Research Update
Feb. 13, 2020
A recent study revealed a natural process that limits the ability of adult blood stem cells to divide to increase their numbers.
Research Update
Feb. 12, 2020
Researchers have developed a new mouse model that mimics the immune system features and gluten-dependent intestinal damage seen in people with celiac disease.
Research Update
Feb. 10, 2020
Scientists have identified novel compounds modulating melatonin receptor activity.
Research Update
Jan. 30, 2020
Researchers have found that elevated maternal blood glucose levels even below those meeting traditional gestational diabetes diagnostic criteria increase health risks in mothers and in their children.
Research Update
Jan. 30, 2020
Due to rapid technological advances made over the past few years, engineered kidney tissues and organoids have emerged as promising tools to accelerate chronic kidney disease research.
Research Update
Jan. 30, 2020
NIDDK-supported research has made important strides toward better understanding pancreatitis in children and contributing to efforts to improve its diagnosis, treatment, and, ultimately, prevention.
Research Update
Jan. 30, 2020
A multifaceted and collaborative research approach has resulted in valuable new knowledge that is moving us closer to type 1 diabetes prevention.
News Release
Jan. 21, 2020
A National Institutes of Health study found that chronic treatment with mirabegron, a drug approved to treat overactive bladder, activated brown fat in a small group of healthy women and had several other beneficial metabolic effects. The research, led by Dr. Aaron Cypess at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), was published online on January 21 in the Journal of Clinical Investigation.
News Release
Dec. 10, 2019
A new strategic plan from the National Institutes of Health outlines efforts to intensify ongoing HBV research with the goals of developing a cure and improving scientific understanding of the virus while creating improved strategies for screening and treating patients.
News Release
Nov. 14, 2019
A specific strain of a common bacteria found in most people with alcoholic hepatitis correlates with greater liver disease severity and mortality, according to a new study published in Nature. Alcoholic hepatitis is a serious form of alcohol-associated liver disease, and people with it have high levels of the bacterium Enterococcus faecalis (E. faecalis) in their gut. The study also found that a novel therapeutic approach that specifically targets the E. faecalis strain lessened alcohol-associated liver disease in mice.
News Release
Nov. 14, 2019
The National Institutes of Health has selected five scientists as Lasker Clinical Research Scholars, part of a joint initiative with the Albert and Mary Lasker Foundation, to foster the next generation of great clinical scientists. This highly competitive program provides talented, early stage researchers the opportunity to carry out independent clinical and translational research for five to seven years at NIH.
Research Update
Nov. 7, 2019
Studies of a protein involved in maintaining fat tissue and regulating metabolism have led to new discoveries about beta cell health in mice, with possible implications for treating diabetes.
Research Update
Nov. 4, 2019
Fundamental new insights into kidney development and organization and how they differ between male and female mice could aid research efforts to battle human kidney diseases.
Research Update
Nov. 1, 2019
Rare variations in the gene SLC30A8 promote release of insulin in response to a rise of blood glucose levels.
Research Update
Oct. 31, 2019
Researchers recently found that a combination of three drugs for cystic fibrosis has substantial benefit in people for whom previous medical treatments did not work.
Research Update
Oct. 23, 2019
Researchers’ recommendations for pregnant women with obesity could help improve obstetrical care for better maternal and infant outcomes.
News Release
Oct. 16, 2019
A multicenter randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that the new system was more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes.
News Release
Oct. 7, 2019
The 2019 Nobel Prize in Physiology or Medicine has been awarded to National Institutes of Health grantees Gregg L. Semenza, M.D., Ph.D., of Johns Hopkins University, and William G. Kaelin Jr., M.D., of Dana-Farber Cancer Institute for their discoveries of how cells sense and adapt to oxygen availability.
Research Update
Oct. 3, 2019
Researchers working with a mouse model have gained insights into the genetic and cellular factors that drive the transformation of circulating immune cells into Kupffer cells, part of the liver’s “special forces”.
News Release
Oct. 3, 2019
Of an estimated 6,500 to 7,000 known rare diseases, only a fraction – maybe 5% – have U.S. Food and Drug Administration-approved treatments. To increase that percentage, the National Institutes of Health has awarded approximately $31 million in grants in fiscal year 2019 to 20 teams – including five new groups – of scientists, clinicians, patients, families and patient advocates to study a wide range of rare diseases.
News Release
Sept. 26, 2019
To reverse the opioid crisis that continues to grip the nation, the National Institutes of Health has awarded $945 million in total fiscal year 2019 funding for grants, contracts and cooperative agreements across 41 states through the Helping to End Addiction Long-term Initiative or NIH HEAL Initiative. The trans-NIH research effort aims to improve treatments for chronic pain, curb the rates of opioid use disorder (OUD) and overdose and achieve long-term recovery from opioid addiction.
News Release
Sept. 9, 2019
Treating preterm infants with antibiotics for more than 20 months appears to promote the development of multidrug-resistant gut bacteria, suggests a study funded by the National Institutes of Health
News Release
Sept. 9, 2019
NIH-funded research project develops new method to preserve human livers for transplantation. Scientists have greatly extended the amount of time human livers can be stored for transplantation by modifying a previous protocol to extend the viability of rat livers.
Research Update
Aug. 29, 2019
Scientists have identified a tell-tale combination of cells in people with Crohn’s disease who do not respond to one of its most effective treatments, revealing potential new targets for therapy.
News Release
Aug. 13, 2019
In a nationwide study, researchers used magnetic resonance imaging (MRI) to scan the brains of hundreds of participants in the National Institutes of Health’s Systolic Blood Pressure Intervention Trial (SPRINT) and found that intensively controlling a person’s blood pressure was more effective at slowing the accumulation of white matter lesions than standard treatment of high blood pressure. The results complement a previous study published by the same research group which showed that intensive treatment significantly lowered the chances that participants developed mild cognitive impairment.
Research Update
Aug. 6, 2019
Scientists have developed a remarkable model of human fatty liver disease using human cells to generate miniature livers in a dish with complex cellular and structural features.
News Release
Aug. 1, 2019
Researchers at the National Institutes of Health developed a new mouse model, called “wildling”, by implanting laboratory mice embryos into wild mice. The wildlings carried the natural microbiome and pathogens of wild mice and mirrored human immune responses better than standard laboratory mice. The mouse model could improve the translation of research in mice into advances in human health.
News Release
July 19, 2019
Researchers show critical association between diabetes and previously unlinked ZRANB3 gene.
Research Update
July 12, 2019
Studies of malnourished children demonstrated that complementary foods designed to boost maturation of the gut microbiome can improve markers of normal growth, neural development, and immune function.
News Release
July 12, 2019
Moderately reducing caloric intake over a period of two years significantly improved cardiometabolic risk factors in young and middle-aged, non-obese adults, according to new findings from the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) trial. The study is a multicenter randomized controlled trial supported by the National Institute on Aging (NIA) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health.
Research Update
July 10, 2019
Research suggests that zebrafish could be used to study the role of sleep in health and disease.
Research Update
June 19, 2019
Researchers identified a unique signature of gene activity levels that predicts survival in young children with biliary atresia—knowledge that could help determine disease progression and inform new treatment approaches.
News Release
June 10, 2019
A treatment affecting the immune system effectively slowed the progression to clinical type 1 diabetes in high risk individuals, according to findings from National Institutes of Health-funded research. The study is the first to show that clinical type 1 diabetes can be delayed by two or more years among people who are at high risk.
News Release
June 10, 2019
A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in adults slowed during medical treatment but resumed after treatment stopped. Youth on the same treatment had markedly poorer outcomes with continued disease progression both during and after the treatment.
News Release
June 7, 2019
Taking a daily vitamin D supplement does not prevent type 2 diabetes in adults at high risk, according to results from a study funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. The Vitamin D and Type 2 Diabetes (D2d) study enrolled 2,423 adults and was conducted at 22 sites across the United States.
News Release
May 30, 2019
Youth who said they were teased or ridiculed about their weight increased their body mass by 33% more each year, compared to a similar group who had not been teased, according to researchers at the National Institutes of Health. The findings appear to contradict the belief that such teasing might motivate youth to change their behavior and attempt to lose weight.
News Release
May 29, 2019
Results from three long-term studies following host and microbiome characteristics during pregnancy and preterm birth, inflammatory bowel disease, and prediabetes have expanded our understanding of how humans and microbes interact and the resulting consequences for our health. The studies were funded as part of a second phase of the National Institutes of Health’s Human Microbiome Project (HMP).
Research Update
May 23, 2019
New research has identified novel subgroups of men with different lower urinary tract symptoms (LUTS) that could help in understanding and treating LUTS in the future.
Research Update
May 19, 2019
Hematopoietic stem cell (HSC) transplants can be life-saving for people with a number of conditions, and two recent studies highlight potential strategies to generate more of these cells for transplant.